Novartis

Merck, Sanofi Animal Health JV to Close Later Than Expected

Novartis to Make Second Offer for Genoptix Shares

Novartis Moves to Stop Execution Drug Reaching US

Sandoz Has 10 Biosimilars in Pipeline

Russia Set for More Inward Pharma Investment

Toshiba Faces $100 Million Gender Bias Lawsuit

Novartis CEO Joe Jimenez: Animal Health Acquisition Makes Sense

M&A Is Back As CEOs Start To Put Cash To Work

Topics • Strategy

Oracle’s Agile PLM Reorganizes Pharma, From Lab to Launch

Topics • Technology

The Pharmaceutical Industry On The Move

Novartis Buys Cancer Diagnosis Specialist Genoptix For $470 Million

EU Drug Watchdog Recommend Against Merck KGaA's Cladribine

EU Drug Watchdog Recommend Against Merck KGaA's Cladribine

EU Presses Pharma Companies for More Info on Patent Deals

Novartis Starts Phase II Trial for Copy of Roche's Rituxan

Genzyme Argues Campath Value In Sanofi Fight

Novartis Takes Over Alcon Ownership for $12.9 Billion

Putin Warns Of Measures Against Global Drug Firms

Severin Schwan of Roche Sees Generic Companies and Innovators As Winners

Novartis to Slash 1,400 U.S. Jobs

Novartis: No Plans to Slash Jobs

Biosimilar Antibodies: EMA Adopts Guideline

Astra Tech: AstraZeneca Confirms Considering Spin-Off

Novartis Won’t Go All-Cash on Alcon Deal

Novartis Efficiency Drive To Boost Profitability

Biosimilar Antibodies: EU Likely to Be Cautious

Novartis Hasn't Ruled out Keeping its 77% Alcon Stake

Bristol-Myers, Lilly Win Major Drug Patent Rulings

EU To Seek Details Of Deals Delaying Generic Drugs

Novartis: $590 Million Q3 Charge as Discontinues Drugs

Novartis to Push Ahead With Disputed Alcon Buyout

Novartis Banking on Swiss Law for Alcon Deal

Novartis/Alcon Deal Cleared by EU Regulators

White Knight Could Be Elusive For Genzyme

Novartis in $175 Million Gender Bias Settlement

18 more articles

Top-Feature

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Interview

Driving Transformation

Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.